MX340571B - Capsula que se desintegra especificamente en el intestino grueso. - Google Patents

Capsula que se desintegra especificamente en el intestino grueso.

Info

Publication number
MX340571B
MX340571B MX2014011760A MX2014011760A MX340571B MX 340571 B MX340571 B MX 340571B MX 2014011760 A MX2014011760 A MX 2014011760A MX 2014011760 A MX2014011760 A MX 2014011760A MX 340571 B MX340571 B MX 340571B
Authority
MX
Mexico
Prior art keywords
capsule
coating film
intestine
disintegrable
disintegrated
Prior art date
Application number
MX2014011760A
Other languages
English (en)
Other versions
MX2014011760A (es
Inventor
Ryosei Kamaguchi
Masafumi Mizutani
Original Assignee
Morishita Jintan Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morishita Jintan Co filed Critical Morishita Jintan Co
Publication of MX2014011760A publication Critical patent/MX2014011760A/es
Publication of MX340571B publication Critical patent/MX340571B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21062—Subtilisin (3.4.21.62)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • General Preparation And Processing Of Foods (AREA)

Abstract

La presente invención es para obtener cápsulas que no se desintegren en el estómago ni en el intestino delgado después de administrarlas oralmente y que se desintegren específicamente en el intestino grueso; la presente invención así proporciona una cápsula que se desintegra específicamente en el intestino grueso, que comprende un contenido que comprende un agente principal y una carcasa que cubre el contenido y que comprende un polímero natural soluble en agua como material base de carcasa y quitosano en polvo que se dispersa en el polímero natural soluble en agua.
MX2014011760A 2012-03-30 2012-09-24 Capsula que se desintegra especificamente en el intestino grueso. MX340571B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012078529A JP5102401B1 (ja) 2012-03-30 2012-03-30 大腸特異崩壊性カプセル
PCT/JP2012/074412 WO2013145379A1 (ja) 2012-03-30 2012-09-24 大腸特異崩壊性カプセル

Publications (2)

Publication Number Publication Date
MX2014011760A MX2014011760A (es) 2015-03-05
MX340571B true MX340571B (es) 2016-07-13

Family

ID=47528495

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014011760A MX340571B (es) 2012-03-30 2012-09-24 Capsula que se desintegra especificamente en el intestino grueso.

Country Status (19)

Country Link
US (1) US8747893B2 (es)
EP (1) EP2832352B1 (es)
JP (1) JP5102401B1 (es)
KR (1) KR101547791B1 (es)
CN (1) CN104321052B (es)
AU (1) AU2012374707B2 (es)
BR (1) BR112014024316B1 (es)
CA (1) CA2868592C (es)
DK (1) DK2832352T3 (es)
ES (1) ES2622295T3 (es)
HU (1) HUE033527T2 (es)
MX (1) MX340571B (es)
MY (1) MY170969A (es)
PH (1) PH12014502191B1 (es)
PL (1) PL2832352T3 (es)
PT (1) PT2832352T (es)
SG (1) SG11201406052XA (es)
TW (1) TWI508754B (es)
WO (1) WO2013145379A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104968356A (zh) * 2012-12-21 2015-10-07 日清药业股份有限公司 大肠输送胶囊及其制备方法
US10272036B2 (en) * 2013-12-06 2019-04-30 Intervet Inc. Composition for oral delivery of bioactive agents
PL3191083T3 (pl) 2014-09-11 2021-07-12 Gelita Ag Cząstki żelatyny/pektyny
EP3205339B1 (en) * 2014-10-06 2022-08-03 Fuji Capsule Co., Ltd. Method of manufacturing enteric seamless soft capsule
JP5989953B1 (ja) * 2015-12-28 2016-09-07 森下仁丹株式会社 粉末状成分含有シームレスカプセルおよびその製造方法
JP6457963B2 (ja) * 2016-02-25 2019-01-23 日清ファルマ株式会社 大腸デリバリーカプセル製剤
JP6250211B1 (ja) * 2017-01-17 2017-12-20 森下仁丹株式会社 水含有カプセル、並びに水含有カプセルの製造方法
EP3741368B1 (en) * 2018-01-18 2024-03-06 Keio University Capsule for use in treating ulcerative colitis
US11980691B2 (en) 2018-03-15 2024-05-14 R.P. Scherer Technologies, Llc Enteric softgel capsules
AU2020370053A1 (en) 2019-10-21 2022-04-21 Soane Pharma LLC Orally ingestible delivery system

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS518176A (ja) 1974-07-11 1976-01-22 Morishita Jintan Co Tsugimenashitankakunijukapuserunoseizohohotokono hohoo jitsushisurutameno seizosochi
JPS60172343A (ja) 1984-02-15 1985-09-05 Akira Horikawa 多重マイクロカプセルの製造法およびその装置
JP2587219B2 (ja) * 1986-06-10 1997-03-05 エーザイ株式会社 溶解遅延性のゼラチン製剤組成物
JPH0813748B2 (ja) 1990-04-23 1996-02-14 帝國製薬株式会社 大腸崩壊性ポリペプチド系経口製剤
JPH064531B2 (ja) 1990-06-04 1994-01-19 アイセロ化学株式会社 大腸崩壊性硬質カプセル
JP3181062B2 (ja) * 1991-01-31 2001-07-03 帝國製薬株式会社 下部消化管崩壊経口製剤
JP3592723B2 (ja) * 1991-02-19 2004-11-24 帝國製薬株式会社 非崩壊・持続性カプセル製剤
JP2916290B2 (ja) * 1991-03-22 1999-07-05 帝國製薬株式会社 生理活性ポリペプチド含有大腸崩壊経口製剤
US5364634A (en) * 1991-11-08 1994-11-15 Southwest Research Institute Controlled-release PH sensitive capsule and adhesive system and method
US5252581A (en) 1992-07-20 1993-10-12 Hoechst-Roussel Pharmaceuticals Inc. Substituted aminothienopyridines, pharmaceutical composition and use
DK0616802T3 (da) * 1992-08-13 1998-10-19 Teikoku Seiyaku Kk Oralt præparat til frigivelse i de nedre fordøjelseskanaler
JP2555520B2 (ja) 1992-12-14 1996-11-20 アイセロ化学株式会社 キトサン硬カプセルおよびその製造法
JP2521229B2 (ja) 1993-06-17 1996-08-07 アイセロ化学株式会社 大腸崩壊性組成物及びその製造法
JPH072650A (ja) 1993-06-18 1995-01-06 Tanabe Seiyaku Co Ltd 放出部位制御型製剤
JPH0710745A (ja) 1993-06-22 1995-01-13 Tanabe Seiyaku Co Ltd 放出開始時間制御型腸デリバリー経口製剤
CA2127392C (en) 1993-07-08 2008-05-27 Hideki Sunohara Process for producing capsule and capsule obtained thereby
JP3102990B2 (ja) * 1993-07-08 2000-10-23 森下仁丹株式会社 カプセルの製造方法およびそれから得られたカプセル
JP3022273B2 (ja) 1995-08-23 2000-03-15 住友金属工業株式会社 連続焼鈍設備における冷延鋼帯の洗浄方法および装置
US6248362B1 (en) 1997-03-26 2001-06-19 Meiji Seika Kaisha, Ltd. Large intestinal delivery composite
JPH10324642A (ja) 1997-03-26 1998-12-08 Meiji Seika Kaisha Ltd 大腸送達性構造体
CA2376261A1 (en) * 1999-06-09 2000-12-14 Mochida Pharmaceutical Co., Ltd. System for release in lower gastrointestinal tract
US6340473B1 (en) * 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
WO2001010467A1 (fr) * 1999-08-09 2001-02-15 Dainippon Pharmaceutical Co., Ltd. Preparations solides contenant de la poudre de chitosane et procede de production associe
JP4524009B2 (ja) 1999-08-09 2010-08-11 大日本住友製薬株式会社 大腸内放出性カプセル製剤
JP4169894B2 (ja) * 1999-12-24 2008-10-22 株式会社三協 ソフトカプセルの製造方法
CN1141974C (zh) * 2000-06-07 2004-03-17 张昊 结肠定位释放的口服生物制剂
CN1285333C (zh) * 2000-06-07 2006-11-22 张昊 结肠定位释放的口服制剂及其制备方法
JP4614258B2 (ja) * 2001-06-12 2011-01-19 森下仁丹株式会社 崩壊性が改良されたソフトカプセル
US7670612B2 (en) * 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
US6974592B2 (en) * 2002-04-11 2005-12-13 Ocean Nutrition Canada Limited Encapsulated agglomeration of microcapsules and method for the preparation thereof
US7670624B2 (en) * 2004-01-29 2010-03-02 Astella Pharma Inc. Gastrointestinal-specific multiple drug release system
EP1727525A4 (en) * 2004-03-23 2009-12-09 Lytone Enterprise Inc CAPSULE CONTAINING CHITOSANE NOYE OR ENCAPSULE
WO2006016595A1 (ja) * 2004-08-10 2006-02-16 Nrl Pharma, Inc. ラクトフェリン複合体及びその製造方法
EP1848729A2 (en) * 2005-01-27 2007-10-31 Ocean Nutrition Canada Limited Chromium-fatty acid compounds and methods of making and using thereof
KR101430018B1 (ko) * 2005-06-21 2014-08-14 브이. 만느 피스 젤란으로 된 파쇄성 심리스 캡슐 및 그 제조방법
US9968120B2 (en) * 2006-05-17 2018-05-15 Dsm Nutritional Products Ag Homogenized formulations containing microcapsules and methods of making and using thereof
US20070034827A1 (en) * 2005-12-02 2007-02-15 Zhixin Li Blends of gelling and non-gelling starches with gellan gums and plasticizer
US20070128285A1 (en) * 2005-07-12 2007-06-07 Chikara Jin Pharmaceutical composition for oral administration
KR101007865B1 (ko) * 2007-06-18 2011-01-14 연세대학교 산학협력단 키토산 및 피틴산을 포함하는 서방성 키토산 캡슐
US8715705B2 (en) * 2009-07-29 2014-05-06 Covidien Lp Multilayer medical devices having an encapsulated edge and methods thereof
JP5496616B2 (ja) 2009-11-18 2014-05-21 フロイント産業株式会社 大腸ドラッグデリバリーシステム製剤
JP5087167B2 (ja) * 2010-12-28 2012-11-28 フロイント産業株式会社 ビフィズス菌大腸デリバリーカプセル及びその製造方法
US20120301546A1 (en) * 2011-05-26 2012-11-29 Hassan Emadeldin M Acid-resistant soft gel compositions

Also Published As

Publication number Publication date
PH12014502191A1 (en) 2014-12-10
HUE033527T2 (en) 2017-12-28
EP2832352B1 (en) 2017-03-29
AU2012374707A1 (en) 2014-10-16
MX2014011760A (es) 2015-03-05
AU2012374707B2 (en) 2015-04-09
PT2832352T (pt) 2017-05-31
BR112014024316A8 (pt) 2018-01-23
WO2013145379A1 (ja) 2013-10-03
CA2868592C (en) 2015-09-22
CA2868592A1 (en) 2013-10-03
EP2832352A4 (en) 2015-04-22
MY170969A (en) 2019-09-23
CN104321052A (zh) 2015-01-28
US8747893B2 (en) 2014-06-10
CN104321052B (zh) 2016-08-17
JP2013209297A (ja) 2013-10-10
KR101547791B1 (ko) 2015-08-26
US20130259933A1 (en) 2013-10-03
ES2622295T3 (es) 2017-07-06
KR20140139606A (ko) 2014-12-05
PL2832352T3 (pl) 2017-08-31
PH12014502191B1 (en) 2014-12-10
EP2832352A1 (en) 2015-02-04
TWI508754B (zh) 2015-11-21
TW201338809A (zh) 2013-10-01
DK2832352T3 (en) 2017-07-10
BR112014024316B1 (pt) 2022-05-31
JP5102401B1 (ja) 2012-12-19
SG11201406052XA (en) 2014-11-27

Similar Documents

Publication Publication Date Title
PH12014502191A1 (en) Capsule disintegrable in large-intestine-specific manner
MY190392A (en) A delayed release drug formulation
MX2019007956A (es) Liberacion autorregulada de ingrediente farmaceutico activo.
WO2011112229A3 (en) Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
IN2014CN00338A (es)
WO2011116963A3 (en) Lipid nanoparticle capsules
BR112013003767A2 (pt) conectores não luer
WO2014100418A3 (en) Orally disintegrating tablet formulation for enhanced bioavailability
SG196810A1 (en) Controlled release pharmaceutical or foodformulation and process for its preparation
MX2015010083A (es) Nanoparticulas biodegradables y clinicamente compatibles como portadores para administracion de farmacos.
WO2011067667A3 (en) Fexofenadine microcapsules and compositions containing them
BR112015029911A2 (pt) bolo alimentar líquido coesivo compreendendo moléculas que fornecem viscoelasticidade
TN2012000507A1 (en) Enteric tablet
WO2012092486A3 (en) Modified release benzimidazole formulations
TR201001417A1 (tr) Geliştirilmiş çözünme hızına sahip sefdinir formülasyonu
PH12016500693A1 (en) Slow-release solid oral compositions
BR112017019364A2 (pt) dispersões sólidas
MX370184B (es) Composición farmacéutica que comprende fingolimod.
MX2019005103A (es) Composiciones de acido gamma-poliglutamico y zinc.
MX2014004480A (es) Complementos alimenticios con disolución bucal rapida.
WO2014045307A3 (en) Pharmaceutical composition
PH12014501822A1 (en) Oral formulation comprising lansoprazole and the preparation method thereof
TN2010000012A1 (en) Stable pharmaceutical composition of a water soluble vinorelbine salt
NZ628867A (en) Pharmaceutical formulation containing flupirtine
IN2014CN02343A (en) Oral formulations containing hyaluronic acid for sustained drug release

Legal Events

Date Code Title Description
FG Grant or registration